2023
Lung Cancer Screening Among Mammography Patients: Knowledge, Eligibility, Participation, and Interest
Novogrodsky E, Haramati L, Villasana-Gomez G, Goldman J, Rosenfeld C, Rosenblum J, Sayre J, Hoyt A, Goldin J, Milch H. Lung Cancer Screening Among Mammography Patients: Knowledge, Eligibility, Participation, and Interest. The Journal Of The American Board Of Family Medicine 2023, 36: 557-564. PMID: 37321658, DOI: 10.3122/jabfm.2022.220423r1.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsEarly Detection of CancerFemaleHumansLung NeoplasmsMammographyMass ScreeningSmokingConceptsLung cancer screeningCancer screeningLung cancerUSPSTF criteriaMammography patientsLung cancer screening eligibilityLung cancer screening participationCancer screening participationAcademic medical centerLow education levelChi-square testMann-Whitney nonparametric testScreening eligibilityUSPSTF guidelinesLDCT screeningEligible womenFormer smokersSmoking historyCurrent smokersScreening participationSingle-page surveyMedical CenterEligibility criteriaPatientsCancerBend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic
Stahl M, Shamah S, Wattamwar K, Furlani A, Serrano M, Haramati L. Bend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic. Clinical Imaging 2023, 100: 1-6. PMID: 37120922, PMCID: PMC10129344, DOI: 10.1016/j.clinimag.2023.04.011.Peer-Reviewed Original ResearchMeSH KeywordsAgedCommunicable Disease ControlCOVID-19Early Detection of CancerFemaleHumansLung NeoplasmsMiddle AgedNew York CityPandemicsRetrospective StudiesTomography, X-Ray ComputedConceptsCancer screening programsLung cancer screening programsScreening programLung cancerPre-pandemic periodCOVID-19 pandemicLung-RADS scorePercentage of examsPandemic periodFirst yearRetrospective cohortAppropriate followPandemic surgeScreening volumeHigh mortalityPatientsCOVID surgeNew York StateCancerCOVID-19Significant differencesDemographic subgroupsCohortFollowInner-city programLung Cancer Screening Penetration in an Urban Underserved County
Lee K, Haramati L, Ye K, Lin J, Mardakhaev E, Gohari A. Lung Cancer Screening Penetration in an Urban Underserved County. Lung 2023, 201: 243-249. PMID: 36892635, DOI: 10.1007/s00408-023-00609-7.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overEarly Detection of CancerEthnicityFemaleHumansLung NeoplasmsMaleMiddle AgedRetrospective StudiesSocial ClassConceptsLung cancer screening programsCancer screening programsRace/ethnicityLung cancerScreening programSocioeconomic statusMethodsThis retrospective cohort studyRetrospective cohort studyInstitutional review board approvalLung cancer screeningUrban medical centerReview board approvalSignificant differencesTwo-sample t-testLower SES neighborhoodsCohort studyMore patientsHispanic patientsCancer screeningCancer cohortUnderserved countiesInclusion criteriaMedical CenterBoard approvalPatients
2022
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening
Joung R, Mullett T, Kurtzman S, Shafir S, Harris J, Yao K, Bilimoria K, Cance W, Nelson H, Abedi A, Acharya S, Adams K, Agarwal R, Agarwal S, Ahmad R, Albaneze P, Aldis K, Allen A, Allman S, Alsen M, Ansteth M, Appiah A, Arentz C, Arias A, Armetta C, Arnold A, Arsene C, Arthur K, Ashton B, Atassi M, Attia S, Bahna H, Bailen L, Baker T, Balan S, Balis A, Balsley A, Barajas D, Barone J, Batchelor B, Bates E, Bayliss T, Beck S, Bennett B, Bennett R, Bennett N, Bensenhaver J, Berby-Todd J, Berrocal J, Bertoni D, Bevan A, Bhatti R, Bier-Laning C, Blackwood M, Blake K, Blankner J, Blansfield J, Blaszkowsky L, Blonigen B, Bloom D, Boatsman J, Boggs J, Bold R, Bollinger D, Bolton C, Boolbol S, Boone G, Borges L, Bouton M, Bovest C, Bowman Seitz T, Boyer C, Boyle C, Bracho F, Bragg A, Branton S, Breslin T, Brock M, Broder A, Brown C, Brown B, Brown H, Brown L, Brown R, Bruce L, Bruce S, Bruton C, Bryant K, Burak W, Burgers J, Busch K, Caba D, Cain J, Campbell M, Campo C, Canavan L, Cannick L, Caputo P, Carr H, Casteel C, Cattaneo S, Cecil A, Celano P, Chambers K, Chambers S, Chin J, Christian M, Chu C, Church A, Clark J, Clark L, Clements M, Cohen S, Cole C, Colemire D, Compton J, Connery C, Constanza-Guaqueta D, Contreras S, Coon A, Copelen K, Corral J, Cosio R, Costas K, Cox A, Cox J, Crane E, Crotzer D, Cruz C, Cygan A, Cyphers L, Czerlanis C, Dale P, Danak S, Dang P, Darcourt J, Davuluri R, Day B, DeAntonio P, Der Y, DiAddezio N, Dietrich L, Diller E, Dodge T, Domenech G, Donovan D, Dubil E, Dunn G, Ebling L, Edsall B, Eftimie B, El Mouallem N, Eladoumikdachi F, Elliott J, Elliott K, Ellis M, Endo K, England T, Ennis C, Everhart T, Evins A, Facktor M, Fadel C, Farrell M, Fawley D, Feldman E, Finan M, Fintel A, Fleshman J, Fogarty S, Fontanilla H, Fontenot E, Foran J, Foss-Blizard C, Frank J, Franz J, Freeman L, Freter R, Fried S, Gabriel R, Galbraith J, Garcia J, Gardner K, Geary K, Gemmel D, Gerlach J, Ghee L, Ghisoli M, Giannone D, Gibbons C, Gillis P, Gilmore D, Gonzalez V, Gooley L, Gorrell C, Grady S, Grew D, Grisby S, Guerra C, Guerriero J, Gupta K, Gynn M, Hafertepen L, Hale C, Hallenbeck R, Hals L, Hammons E, Haramati L, Harper N, Harris J, Harrison M, Harrison M, Hassapis J, Haverlock B, Hawley A, Hayden T, Hayes C, Hayes D, Headen C, Hehnly E, Heikens S, Heinzman S, Herring M, Hill M, Hirner P, Hobbs K, Hordyk H, Horning N, Howard D, Huang K, Hughes C, Hughes J, Huibregtse C, Huitt N, Hunsucker L, Inverso T, Irwin T, Isbell M, Jabbour N, Jackson M, Jackson R, Jacob-Perez S, Jafri N, Jahania S, Jarrett A, Jenkinson S, Johnson R, Johnson A, Johnson D, Johnson P, Johnston C, Jones R, Jones S, Joseph J, Joseph N, Joyner R, Juarez-Perez M, Kaczmarski K, Kakani V, Kamran A, Kanaan S, Kang T, Kannarkatt J, Kanneganti S, Kantharaj B, Kaufman H, Keeler V, Keiser S, Kennedy M, Khan I, Khan R, Kibel L, Kiernan M, Kim B, Kinnaird A, Kipping-Johnson K, Kirkland P, Kirshnan S, Klaff L, Kloss R, Klotz J, Knight S, Koch J, Kocheril P, Kodali D, Kohli M, Koko I, Kong A, Kozyreva O, Kraft L, Krisher S, Kruse E, Kupstas A, Kurian M, Kwait R, Lan C, Lanciano R, Lannon W, Laster S, LaTrenta L, Law S, Le I, Lean N, Leatherbury K, Lee J, Leete T, Legenza M, Leung W, Li J, Likhacheva A, Lingerfelt B, Llaguna O, Longo L, Loop M, Lopez N, Loporchio N, Lowney J, Lozoraitis C, Lu K, Lue D, Lush R, Luyimbazi D, Lyons D, Macedo F, Machenzie M, Mack D, Mack J, MacVicar J, Mah K, Mahoney K, Makani N, Makower D, Malad S, Maldonado C, Malik F, Malone A, Mantha S, Marczak K, Margolis N, Mashanic K, Mathison J, Mauzy T, Maxwell L, McAllaster J, McCarthy C, McClune J, McColgan J, McCusker T, McDaniel D, McFayden L, McGivney R, McGovern K, McKeever H, McManus S, McNair K, McNeil H, McRae J, Medrano C, Mehta P, Merrigan T, Meyers E, Mickey S, Miller J, Miller L, Miller S, Mink T, Miranda J, Mitchell M, Monroe J, Moore J, Morin-Ducote G, Moritz T, Morris P, Mukherjee S, Mullally S, Mulligan M, Mullins D, Mullins M, Munoz I, Murdock J, Myers S, Nair S, Nandamuri K, Nicholls J, Nick D, Nish A, Nowell A, Nowell K, O'Connor L, O'Neill J, O'Riordan M, Ogunkunle R, Opsasnick M, Ortiz C, Osgood R, Oxenberg J, Page B, Palmer J, Parikh D, Park D, Partin J, Passwater C, Patel M, Patrick J, Patterson S, Pearson L, Peiffer S, Peralta E, Peterson M, Pettus B, Pezzulo J, Pfarr M, Phelps C, Phillips L, Pick M, Piephoff J, Pinkston J, Piper J, Pollak S, Ponec R, Popalzai M, Pories S, Prieto R, Proctor K, Provost K, Prow D, Puc M, Purdon M, Quaranta B, Quinlan-Davidson S, Rabines A, Rahman R, Ramasubbaiah R, RamĂrez-Solá M, Randolph D, Raskin E, Rasmussen L, Rasmussen N, Rasmussen R, Reed C, Reese S, Regis S, Reilly J, Reitherman R, Reneau C, Renfroe C, Renn C, Reyna C, Rieger-Christ K, Ringer R, Rizack T, Rizwan U, Robinson W, Robles-Rodriguez E, Rogers E, Ronk M, Rossidis G, Rovito M, Roy A, Roybal L, Ruggiero G, Ruskin R, Ryan J, Sachdeva K, Saffie A, Sall N, Salters D, Sanchez J, Sandborn J, Sarap M, Sarap M, Sasaki J, Schallenkamp J, Schilder L, Schlesinger K, Scholl J, Scoppetuolo M, Scott J, Sexton W, Seydel A, Shackour M, Shah A, Shah M, Sharif S, Shaw C, Shehata A, Shelton C, Shields R, Shilad S, Shively E, Shriner M, Siebentritt J, Singhal S, Sinha S, Sinha S, Slotkin J, Smith K, Smith S, Smith-Marrone S, Sobel L, Sobolewski A, Sobolewski R, Solomon N, Songy T, Sonnier F, Sorenson L, Sorto J, Souza W, Spector D, Spigelman Z, Steitz B, Stephens C, Stewart S, Stipec G, Stith B, Street H, Subramanian J, Sumrall M, Sundermeyer M, Syed A, Szwerc M, Tanner L, Tatum T, Taveira R, Taylor M, Taylor J, Teal C, Tello-Skjerseth C, Terhaar K, Terhar M, Thind R, Thomas K, Thompson N, Thomson C, Tieu B, Toke M, Tomita M, Tomkovich K, Tong E, Tothy P, Tran M, Travis-Soper K, Trikha G, Trikha G, Vasnani R, Veeramachaneni N, Veerapaneni A, Ventura-Cullen D, Vester D, Vinsky J, Visioni A, Vlaminck L, Wadhera A, Wagner J, Waits B, Walenga S, Walker M, Wallace L, Wallace J, Ward M, Warmington K, Wasley R, Watson K, Watson W, Waxman J, Weathersby R, Weaver E, Weber M, Weiselberg C, Wesen C, Wexler A, Weyer D, White P, White C, Whitefield K, Wilkinson R, Willey J, Williams V, Wilson J, Witt V, Wold H, Woodford D, Woomer S, Wray J, Yeh K, Yoon-Flannery K, Zera R, Zlomke M, Zummo K, Zwicky K. Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening. JAMA Network Open 2022, 5: e2242354. PMID: 36383381, PMCID: PMC9669819, DOI: 10.1001/jamanetworkopen.2022.42354.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19Early Detection of CancerHumansMass ScreeningNeoplasmsPandemicsQuality ImprovementConceptsCancer screeningPreintervention periodScreening interventionsCancer programsNational Quality Improvement CollaborativeQI studiesQI projectCancer-related deathQuality Improvement CollaborativeAdditional screening testInterrupted time series analysisNationwide quality improvementsQI supportPrimary outcomeCancer careHospital characteristicsIntervention periodPrepandemic periodQI interventionsMAIN OUTCOMEPreintervention trendsDisease sitesScreening testIntervention effectsQI teams
2020
Meeting ACR Dose Guidelines for CT Lung Cancer Screening in an Overweight and Obese Population
Peng R, Mardakhaev E, Shmukler A, Levsky J, Haramati L. Meeting ACR Dose Guidelines for CT Lung Cancer Screening in an Overweight and Obese Population. Academic Radiology 2020, 28: 381-386. PMID: 32284173, DOI: 10.1016/j.acra.2020.02.009.Peer-Reviewed Original ResearchMeSH KeywordsBody Mass IndexEarly Detection of CancerFemaleHumansLung NeoplasmsMaleObesityOverweightRadiation DosageTomography, X-Ray ComputedConceptsBody mass indexLung cancer screeningBMI classificationDose guidelinesObese patientsDose metricsObese populationCancer screeningLung cancerCT lung cancer screeningRadiation doseMedian effective doseLow radiation doseMass indexStudy populationAmerican CollegeObesity epidemicDose requirementsEffective doseClinical programsPatientsDoseWomenSignificant differencesCTDIvolPerformance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort
Kessler A, Peng R, Mardakhaev E, Haramati L, White C. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort. Radiology Imaging Cancer 2020, 2: e190021. PMID: 33778703, PMCID: PMC7983652, DOI: 10.1148/rycan.2020190021.Peer-Reviewed Original ResearchMeSH KeywordsAgedEarly Detection of CancerFemaleHumansLungLung NeoplasmsMaleMass ScreeningMiddle AgedRetrospective StudiesTomography, X-Ray ComputedUnited StatesConceptsLung CT Screening ReportingLung-RADSFalse-negative findingsRadiology's Lung CT Screening ReportingLung cancer screening cohortAccountability Act-compliant retrospective studyLung cancer screening programsLung-RADS scoreInstitutional review board approvalCancer screening programsLung nodulesLung cancer screeningRisk of cancerReview board approvalDiverse clinical settingsMean followScreening cohortRetrospective studyRisk calculatorCancer screeningLung cancerScreening programStudy populationLung cancer detectionAmerican College
2019
Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial
White C, Dharaiya E, Dalal S, Chen R, Haramati L. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial. Radiology 2019, 291: 205-211. PMID: 30667335, DOI: 10.1148/radiol.2018181050.Peer-Reviewed Original ResearchMeSH KeywordsAgedEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMiddle AgedMultiple Pulmonary NodulesRisk AssessmentSolitary Pulmonary NoduleTomography, X-Ray ComputedConceptsNational Lung Screening TrialLung-RADSLung Imaging ReportingPatient basisRisk calculatorScreening TrialImaging ReportingRadiology Lung Imaging ReportingRisk of malignancyAmerican CollegeSolid nodulesSubsolid nodulesNodule basisMalignancyTotal nodulesNodulesData SystemTrialsSpecificityPatientsReporting
2018
Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community
Su C, Bhargava A, Shah C, Halmos B, Gucalp R, Packer S, Ohri N, Haramati L, Perez-Soler R, Cheng H. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community. Clinical Lung Cancer 2018, 19: e767-e773. PMID: 29937386, DOI: 10.1016/j.cllc.2018.05.019.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAgedCarcinoma, Squamous CellCombined Modality TherapyDecision Support TechniquesEarly Detection of CancerFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMedically Underserved AreaMiddle AgedPrognosisRetrospective StudiesSmall Cell Lung CarcinomaSurvival RateTomography, X-Ray ComputedUrban PopulationConceptsUnited States Preventative Services Task Force guidelinesPrimary lung cancerTask Force guidelinesLung cancerScreening TrialMortality differencesPrimary care provider statusScreen-detected lung cancersNational Lung Screening TrialLung cancer-related mortalityLung Cancer Screening TrialActive smoking statusTime of diagnosisCancer Screening TrialCancer-related mortalityUnderserved communitiesUrban underserved communitiesLCS eligibilityCause mortalityPatient characteristicsProspective trialCurative treatmentSmoking statusSurgical managementCox regression
2015
Computed Tomography Screening for Lung Cancer
Milch H, Kaminetzky M, Pak P, Godelman A, Shmukler A, Koenigsberg T, Haramati L. Computed Tomography Screening for Lung Cancer. Journal Of Thoracic Imaging 2015, 30: 157-163. PMID: 25532712, DOI: 10.1097/rti.0000000000000123.Peer-Reviewed Original ResearchMeSH KeywordsEarly Detection of CancerHumansLung NeoplasmsMass ScreeningTomography, X-Ray ComputedUrban PopulationConceptsLung cancerCT screeningNational Lung Screening Trial eligibility criteriaOverall populationCT lung cancer screeningDiverse inner-city populationLung cancer prevalencePercent of patientsStage 1 diseaseLung cancer screeningCT lung cancerComputed Tomography ScreeningTrial eligibility criteriaInner-city populationElectronic medical recordsBaseline characteristicsCurrent smokersMortality benefitCT findingsTomography screeningObese populationStage IIATrial populationCancer screeningCancer prevalence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply